BIO 2019 Notebook: Merck; Out-Licensing Deals; RMAT

 
• By Joseph Haas and Sue Sutter
Bio 2019 Notebook for Scrip
Merck & Co. exec outlines one proposed "pull incentive" for antibiotic research called the Market Entry Reward. • Source: Shutterstock

More from Cell Therapies

More from Advanced Therapies